HK1072010A1 - Topical dapsone for the treatment of acne - Google Patents

Topical dapsone for the treatment of acne

Info

Publication number
HK1072010A1
HK1072010A1 HK05104930A HK05104930A HK1072010A1 HK 1072010 A1 HK1072010 A1 HK 1072010A1 HK 05104930 A HK05104930 A HK 05104930A HK 05104930 A HK05104930 A HK 05104930A HK 1072010 A1 HK1072010 A1 HK 1072010A1
Authority
HK
Hong Kong
Prior art keywords
acne
treatment
dapsone
composition
topical dapsone
Prior art date
Application number
HK05104930A
Other languages
English (en)
Inventor
Osborne W David
Original Assignee
Qlt Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qlt Usa Inc filed Critical Qlt Usa Inc
Publication of HK1072010A1 publication Critical patent/HK1072010A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Floor Finish (AREA)
HK05104930A 2002-02-20 2005-06-13 Topical dapsone for the treatment of acne HK1072010A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/081,050 US20030157036A1 (en) 2002-02-20 2002-02-20 Topical dapsone for the treatment of acne
PCT/US2002/008449 WO2003072071A1 (en) 2002-02-20 2002-03-18 Topical dapsone for the treatment of acne

Publications (1)

Publication Number Publication Date
HK1072010A1 true HK1072010A1 (en) 2005-08-12

Family

ID=27733245

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104930A HK1072010A1 (en) 2002-02-20 2005-06-13 Topical dapsone for the treatment of acne

Country Status (23)

Country Link
US (2) US20030157036A1 (xx)
EP (1) EP1485059B1 (xx)
JP (1) JP2005524651A (xx)
KR (1) KR100864129B1 (xx)
CN (1) CN1625384A (xx)
AT (1) ATE353628T1 (xx)
AU (1) AU2002306767B2 (xx)
BR (1) BR0215606A (xx)
CA (3) CA2776702C (xx)
DE (1) DE60218227T2 (xx)
DK (1) DK1485059T3 (xx)
EA (1) EA008022B1 (xx)
ES (1) ES2280629T3 (xx)
HK (1) HK1072010A1 (xx)
IL (1) IL163650A0 (xx)
IS (1) IS2454B (xx)
MX (1) MXPA02006593A (xx)
NO (1) NO20043877L (xx)
NZ (1) NZ535363A (xx)
PT (1) PT1485059E (xx)
SI (1) SI1485059T1 (xx)
WO (1) WO2003072071A1 (xx)
ZA (1) ZA200407439B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097030A1 (en) * 2002-05-21 2003-11-27 Immune Network Ltd. Use of 4-(4'-aminophenylsulphonyl)-benzoic acid and esters thereof as anti-inflammatory agents
EP1675563A4 (en) * 2003-08-13 2009-07-15 Qlt Usa Inc EMULSION COMPOSITION WITH DAPSON
US20060286108A1 (en) * 2005-06-16 2006-12-21 Bell Katherine A Topical compositions for the treatment of chronic wounds
KR100806051B1 (ko) 2006-09-06 2008-02-26 오교철 답손을 유효성분으로 함유하는 항진균용 약학 조성물
US20100112021A1 (en) * 2007-03-21 2010-05-06 Xiaodong Zhang Sustained-release composition
US20090041686A1 (en) * 2007-08-06 2009-02-12 Osborne David W Topical acne vulgaris composition with a sunscreen
US20110294896A1 (en) * 2007-11-07 2011-12-01 Garret John S Topical Treatment With Dapsone In G6PD-Deficient Patients
US8586010B2 (en) * 2008-02-27 2013-11-19 Allergan, Inc. Dapsone to treat rosascea
CA2769640A1 (en) * 2009-07-30 2011-02-03 Allergan, Inc. Combination of dapsone with adapalene
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
CN103054792B (zh) * 2011-10-21 2017-06-06 重庆华邦制药有限公司 一种质量稳定的氨苯砜凝胶及其制备方法
KR20130063962A (ko) * 2011-12-07 2013-06-17 가천대학교 산학협력단 디아미노디페닐술폰을 포함하는 골량 저하 질환의 예방 또는 치료용 약학적 조성물
BR112015011673B1 (pt) * 2012-11-20 2021-03-09 Allergan, Inc. composição e uso da mesma
US20160051499A1 (en) * 2014-07-31 2016-02-25 Allergan, Inc. Comparative efficacy and tolerability of dapsone 5% in adult versus adolescent females with acne vulgaris
JP6951332B2 (ja) * 2015-11-04 2021-10-20 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 局所用ダプソン組成物を使用して尋常性座瘡を処置する方法
CN115887357B (zh) * 2022-11-28 2023-07-11 哈尔滨葵花药业有限公司 氨苯砜凝胶制剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3419009A1 (de) * 1984-05-22 1985-11-28 Dr. Karl Thomae Gmbh, 7950 Biberach Neue substituierte bis(4-aminophenyl)sulfone, ihre herstellung und ihre verwendung als arzneimittel
DE3603577A1 (de) * 1986-02-06 1987-08-13 Joachim K Prof Dr Seydel Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US6277399B1 (en) * 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6254866B1 (en) * 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
US6248324B1 (en) * 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
US6056955A (en) * 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
US20040086469A1 (en) * 2002-10-30 2004-05-06 Osborne David W. Protectant for UV-induced skin damage

Also Published As

Publication number Publication date
DE60218227D1 (de) 2007-03-29
KR100864129B1 (ko) 2008-10-16
NO20043877L (no) 2004-09-15
EA008022B1 (ru) 2007-02-27
AU2002306767B2 (en) 2007-09-13
US20070122435A1 (en) 2007-05-31
AU2002306767B9 (en) 2003-09-09
CA2855045A1 (en) 2003-09-04
BR0215606A (pt) 2004-12-07
CN1625384A (zh) 2005-06-08
CA2776702C (en) 2014-09-02
CA2776702A1 (en) 2003-09-04
CA2477217A1 (en) 2003-09-04
NZ535363A (en) 2007-04-27
IS7419A (is) 2004-08-20
IS2454B (is) 2008-11-15
MXPA02006593A (es) 2004-08-19
DE60218227T2 (de) 2007-10-31
US20030157036A1 (en) 2003-08-21
DK1485059T3 (da) 2007-05-07
EP1485059A1 (en) 2004-12-15
EP1485059A4 (en) 2005-09-21
ZA200407439B (en) 2006-06-28
SI1485059T1 (sl) 2007-06-30
IL163650A0 (en) 2005-12-18
EP1485059B1 (en) 2007-02-14
PT1485059E (pt) 2007-04-30
AU2002306767A1 (en) 2003-09-09
ES2280629T3 (es) 2007-09-16
EA200401084A1 (ru) 2005-08-25
KR20040085214A (ko) 2004-10-07
CA2477217C (en) 2012-07-17
JP2005524651A (ja) 2005-08-18
ATE353628T1 (de) 2007-03-15
WO2003072071A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
HK1072010A1 (en) Topical dapsone for the treatment of acne
TW200505508A (en) Methods of administering a dermatological agent to a subject
WO2004043481A3 (en) Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
AU3142195A (en) Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
WO2003024436A3 (en) Method for treating skin disorders
WO2006006167A3 (en) Compositions and methods for dermatological wound healing
TW200513271A (en) Topical treatment of skin conditions
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
WO2003099270A8 (en) Methods of treating allergic reactions
WO2004000227A3 (en) Use of thio-oxindole derivatives in treatment of skin disorders
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
WO2007106622A3 (en) Fungicidal formulation and method of use
WO2003039453A3 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
BRPI0412424A (pt) composto, composição farmacêutica, método para tratar doenças dermatológicas ou cancerosas em um mamìfero, composição, e, método para tratar doenças relacionadas com a pele ou cancerosas
BRPI0410358A (pt) tratamento tópico de condições da pele
ATE554757T1 (de) Verwendung von mindestens einem 2-alkyl-furan als wirkstoff zur depigmentierung oder aufhellung
WO2004071413A3 (en) Method and composition for potentiating an opiate analgesic
WO2001066101A3 (en) Treatment of psoriasis
AP1777A (en) Use of topical compositions for the control of microbial diseases of the nail.
WO2002041832A8 (en) Compositions having comfrey and methods for reducing retinoid-induced skin irritation
WO2000073274A3 (de) Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung als adenosinaufnahme-inhibitoren
AU2003258553A1 (en) Metal cluster nano-compounds for treating tumor diseases
MXPA99007442A (es) Composiciones retinoides topicas y de serinaproteasa.
WO1998047494A3 (en) Novel use of matrix metalloproteinase inhibitors
AU2001285419A1 (en) Methods and compositions for treating skin ulcers by topical photodynamic therapy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120318